##plugins.themes.bootstrap3.article.main##

Mojgan Barati Elham Sohrabi Dehaghani Mahvash Zargar Najmieh N. Saadati Nastaran Ranjbari

Abstract

Objective: Evaluating the preeclampsia, placental pathology, maternal and fetal features in women with gestational hypertension (GH) at varying gestational ages.


Methods: A series of maternal, fetal, placental pathological, and neonatal variables were prospectively evaluated and compared between two 30-tuple groups of eligible pregnant women with early GH before 34 weeks' gestation and those with late GH after 34 weeks' gestation.


Results: Proteinuria and preeclampsia were more prevalent in the early GH group compared with the late GH group (80% vs 20%, P:0.001). The maternal high blood pressure and proteinuria were significantly associated with the early GH and preeclampsia (p<0.05). The percentage of syncytial knots significantly increased as preeclampsia progressed (P<0.05). A significant positive correlation existed between the early GH and the percentage of newborns admitted to NICU, the length of hospitalization, and the levels of the doppler indexes of umbilical and uterine arteries (p<0.05); the newborn Apgar scores were also lower in the early GH group (p<0.05). The mortality rate of newborns born to early hypertensive mothers (13.30%) was insignificantly higher than those delivered by the late hypertensive mothers (3.30%, p:0.16).


Conclusion: Maternal high blood pressure and proteinuria may be predicting risk factors for the early GH and/or preeclampsia. The placentas of women with early GH were partially different from those with GH after 34 weeks' gestation. Higher rates of maternal and fetal pregnancy-related complications in the early GH group may be indicative of the different effects of GH and preeclampsia on pregnancy outcomes depending on the gestational age.

##plugins.themes.bootstrap3.article.details##

##plugins.themes.bootstrap3.article.details##

Keywords
References
1. Tavakolipour Sh, Beigi M, Nekuei N, Shafiei F. The Prevalence of Pregnancy Hypertensive Disorders and Their Related Factors in the Second and Third Level Hospitals Affiliated to Isfahan University of Medical Sciences, Isfahan, Iran. JMRH. 2019;7(3):1736-1741. https://jmrh.mums.ac.ir/article_12270.html
2. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY. Prenatal care, Pregnancy Hypertension, and Obesity In: Cunningham FG, ed. Williams Obstetrics. New York: McGraw-Hill; 2010, p. 176–177, p. 706,–714, p. 964–965.
3. Mol BW, Roberts CT, Thangaratinam S, Magee LA, de Groot CJ, Hofmeyr GJ. Pre-eclampsia. Lancet. 2016;387: 999–1011. https://www.thelancet.com/article/S0140-6736(20)32335-7/fulltext
4. Shen M, Smith GN, Rodger M, White RR, Walker MC, Wen SW. Comparison of risk factors and outcomes of gestational hypertension and pre-eclampsia. PLoS One. 2017;12(4):e0175914. https://pubmed.ncbi.nlm.nih.gov/28437461/
5. Pan ML, Chen LR, Tsao HM, Chen KH. Risk of gestational hypertension-preeclampsia in women with preceding endometriosis: A nationwide population-based study. PLoS One. 2017;12(7):e0181261. https://pubmed.ncbi.nlm.nih.gov/28715497/
6. Kordi M, Vahed A, Rezaee T, Fariborz M, Seyed Reza M, Lotfalizadeh M. Anxiety during pregnancy and preeclampsia: a case - control study. JMRH. 2017;5(1):814-820. https://jmrh.mums.ac.ir/article_7881.html
7. Pankiewicz K, Szczerba E, Maciejewski T, Fijałkowska A. Non-obstetric complications in preeclampsia. Prz Menopauzalny. 2019;18(2):99-109. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719635/
8. Kongwattanakul K, Saksiriwuttho P, Chaiyarach S, Thepsuthammarat K. Incidence, characteristics, maternal complications, and perinatal outcomes associated with preeclampsia with severe features and HELLP syndrome. Int J Womens Health. 2018;10:371-377. https://pubmed.ncbi.nlm.nih.gov/30046254/
9. Ilekis JV, Tsilou E, Fisher S, Abrahams VM, Soares MJ, Cross JC, et al. Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Am J Obstet Gynecol. 2016;215(1 Suppl):S1-S46. https://pubmed.ncbi.nlm.nih.gov/26972897/
10. Staff AC, Fjeldstad HE, Fosheim IK, Moe K, Turowski G, Johnsen GM, et al. Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia. Am J Obstet Gynecol. 2020;S0002-9378(20)31116-9. https://pubmed.ncbi.nlm.nih.gov/32971013/
11. Hauspurg A, Redman EK, Assibey-Mensah V, Tony Parks W, Jeyabalan A, Roberts JM, et al. Placental findings in non-hypertensive term pregnancies and association with future adverse pregnancy outcomes: a cohort study. Placenta. 2018;74:14-19. https://pubmed.ncbi.nlm.nih.gov/30594310/
12. Stanek J. Placental pathology varies in hypertensive conditions of pregnancy. Virchows Arch. 2018;472(3):415-423. https://pubmed.ncbi.nlm.nih.gov/28971254/
13. Sarafzadeh A, Jamalou M, Roustaei Z. Placental Pathologies in the Preterm Labors. SJRM. 2018;2(2):59-64. http://saremjrm.com/browse.php?a_id=97&slc_lang=en&sid=1&printcase=1&hbnr=1&hmb=1
14. Poon L.C., Shennan A., Hyett J.A., Kapur A., Hadar E., Divakar H., et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int. J. Gynaecol. Obstet. 2019;145:1–33. https://pubmed.ncbi.nlm.nih.gov/31111484/
15. Lewandowska M., Sajdak S., Lubiński J. Serum Selenium Level in Early Healthy Pregnancy as a Risk Marker of Pregnancy Induced Hypertension. Nutrients. 2019;11:1028. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566672/
16. Nelson D. B., Ziadie M. S., McIntire D. D., Rogers B. B., & Leveno, K. J. Placental pathology suggesting that preeclampsia is more than one disease. AJOG. 2014;210(1):66.e1–66.e7. https://pubmed.ncbi.nlm.nih.gov/24036400/
17. Ezeigwe CO, Okafor CI, Eleje GU, Udigwe GO, Anyiam DC. Placental Peripartum Pathologies in Women with Preeclampsia and Eclampsia. Obstet Gynecol Int. 2018;2018:9462938. https://pubmed.ncbi.nlm.nih.gov/30327674/
18. Poorolajal J, Jenabi E. The association between body mass index and preeclampsia: a meta-analysis. J Matern Fetal Neonatal Med. 2016;29(22):3670-6. https://pubmed.ncbi.nlm.nih.gov/26762770/
19. Awuah SP, Okai I, Ntim EA, Bedu-Addo K. Prevalence, placenta development, and perinatal outcomes of women with hypertensive disorders of pregnancy at Komfo Anokye Teaching Hospital. PLoS One. 2020;15(10):e0233817. https://pubmed.ncbi.nlm.nih.gov/33119603/
20. Adekanmi AJ, Roberts A, Akinmoladun JA, Adeyinka AO. Uterine and umbilical artery doppler in women with pre-eclampsia and their pregnancy outcomes. The Nigerian Postgraduate Medical Journal. 2019;26(2):106-112. https://pubmed.ncbi.nlm.nih.gov/31187750/
Section
Original Articles